EMD Serono

EMD Serono discovers and develops biopharmaceutical products. The company focuses on specialized areas such as neurodegenerative diseases, fertility, metabolic endocrinology, and oncology. It offers GONAL-f RFF Pen, a pre-filled and ready-to-use multi-dose FSH for the treatment of infertility; Ovidrel pre-filled syringe, an immediate-injection liquid infertility treatment; Luveris, a recombinant human luteinizing hormone; and Cetrotide, a gonadotropin-releasing hormone antagonist. The company also provides Saizen for growth hormone deficiency in children and adults; Serostim for HIV-associated wasting; Zorbtive for short bowel syndrome; and Rebif for relapsing-remitting multiple sclerosis (MS). Additionally, it offers Fertility Lifeline, an educational service that provides personalized information and support to individuals at all stages of their patient journey. The company distributes its products through distributors.